arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Larimar Therapeutics, Inc.

LRMR

$4.16 ▼ -0.03 (-0.72%) at close

15 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Larimar Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -220.9% ↘

FCF / Share None

Trailing P/E —

Price / Book 4.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-165.67M

↓ -105.5% —

FCF / Share Free cash flow per share

$-1.16

↓ -51.9% —

Long-Term Debt Long-term obligations

$14.54M

↓ -27.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
EPS Growth YoY (%)	—	-57.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	38.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	53.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	17.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-105.5% Weak ↓ Weak Declining Year-over-year change in net income	-118.1% Weak ↓ Weak Declining Year-over-year change in net income	-4.5% Weak ↓ Weak Declining Year-over-year change in net income	30.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-19.2% Weak ↓ Weak Declining Year-over-year change in net income	6.4% Fair ↑ Fair Improving Year-over-year change in net income	26.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-18.0% Weak ↑ Weak Improving Year-over-year change in net income	10.1% Fair ↑ Fair Improving Year-over-year change in net income	22.1% Good ↑ Good Improving Year-over-year change in net income	-103.6% Weak ↓ Weak Declining Year-over-year change in net income	-160.1% Weak Weak Year-over-year change in net income	-1.1% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	-51.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	28.7% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	56.6% Excellent Excellent Year-over-year change in free cash flow	30.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-220.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-51.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-32.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-67.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-67.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	25.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-118.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-43.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-28.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-36.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-212.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1514%)	-46.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-413%)	-45.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-31.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	-78.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-624%)	-47.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-416%)	-84.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-664%)	-65.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-539%)	-66.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-543%)	-47.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-417%)	-43.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	-34.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-333%)	20.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	25.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+69%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	0.27x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-55%)	0.21x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	—	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	-25.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-32.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-321.21x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-110.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-91.58x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-40.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-142.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-85.41M	$-33.22M	$-26.75M	$-26.82M	$-70.10M	$-68.15M	$-12.67M	$-29.33M	$-40.78M	$-29.17M	$-35.59M	$-58.10M	$-35.52M	$-9.94M	$-1.47M
Debt / EBITDA (x)	—	—	—	—	—	—	-0.32x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Basic EPS, GAAP (USD)	—	$-1.32	$-0.84	$-1.37	$-2.95	$-3.57	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-1.16	$-0.77	$-1.07	$-2.47	$-3.56	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.94	$2.69	$1.86	$2.56	$3.64	$5.84	$1.43	$2.50	$2.85	$4.45	$6.21	$4.56	$-94.02	—	—
Tangible Book Value per Share (USD)	$0.94	$2.69	$1.86	$2.56	$3.64	$5.84	$1.43	$2.50	$2.85	$4.45	$6.21	$4.56	$-94.02	—	—
Basic Weighted Avg Shares (shares)	—	61.26M	43.90M	25.76M	17.16M	11.88M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$77.23M	$170.95M	$80.67M	$110.03M	$63.36M	$88.96M	$59.31M	$108.02M	$97.63M	$121.00M	$171.57M	$110.30M	$34.44M	—	—
LT Debt (USD)	—	—	—	—	—	—	$14.54M	$20.00M	—	$3.18M	—	—	—	—	—
Total Equity (USD)	$78.08M	$171.81M	$81.72M	$110.90M	$64.41M	$89.69M	$53.62M	$93.27M	$78.22M	$121.73M	$169.11M	$104.44M	$-68.57M	$-54.73M	$-40.92M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—
Depreciation Expense (USD)	$350.00K	$318.00K	$311.00K	$318.00K	$326.00K	$155.00K	$263.00K	$261.00K	$188.00K	$212.00K	$70.00K	$16.00K	$12.00K	$11.00K	—
Net Income, GAAP (USD)	$-165.67M	$-80.60M	$-36.95M	$-35.35M	$-50.64M	$-42.48M	$-45.41M	$-61.37M	$-52.03M	$-57.88M	$-74.29M	$-36.48M	$-14.03M	$-13.88M	—
Operating Cash Flow (USD)	$-113.20M	$-70.76M	$-33.46M	$-27.57M	$-42.10M	$-42.20M	$-40.78M	$-51.49M	$-43.78M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 55 quarters

Larimar Therapeutics, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare LRMR with peers